Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Financial Times

12:51 EST 13th November 2018 | BioPortfolio

Here are the most relevant search results for "Financial Times" found in our extensive news archives from over 250 global news sources.

More Information about Financial Times on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Financial Times for you to read. Along with our medical data and news we also list Financial Times Clinical Trials, which are updated daily. BioPortfolio also has a large database of Financial Times Companies for you to search.

Showing News Articles 1–25 of 656 from Financial Times

Tuesday 13th November 2018

Bayer reports flat earnings, plans to challenge weedkiller ruling

The company said full-year sales would be in line with guidance

Monday 12th November 2018

Takeda/Japan activism: importunate imports

Unhappy shareholders are right to resist the purchase of Shire

Takeda and Shire to pay almost $1bn in deal fees

Bankers, lawyers and PR advisers to receive huge payday for Japan’s largest overseas takeover

Takeda sets date for shareholder vote on £46bn Shire deal

Closely watched meeting comes as some shareholders step up campaign to derail deal

Saturday 10th November 2018

AstraZeneca diabetes drug cuts complications

Farxiga reduces heart failure and kidney damage during clinical trials

Friday 9th November 2018

Global funding lift, George Gao, AI and doctors

Thursday 8th November 2018

Sainsbury’s tries to hit right notes to win over critics

Mike Coupe needs to stress how competitive and unprofitable supermarkets can be

AstraZeneca: back from the abyss

Results may appear unimpressive but there is reason to be cheerful

AstraZeneca shares surge as new drugs fuel growth

Drugmaker says its first quarter of product sales growth since 2014 ‘marks important day’

AstraZeneca pins hopes on new drugs as profits slump

Drugmaker says its first quarter of product sales growth since 2014 ‘marks important day’

Hikma and Vectura agree to develop generic rival to asthma drug

AstraZeneca profits slump but company pins hopes on new drugs

The pharmaceutical company said product sales were on an upward trajectory

Wednesday 7th November 2018

Africa’s warp-speed health revolution has dangers

Poor countries must devote more resources to urban planning and improving sanitation

Tuesday 6th November 2018

CVS Health says Aetna acquisition to close before Thanksgiving

AstraZeneca sells trio of respiratory drugs for $350m

Monday 5th November 2018

Mylan posts earnings beat despite weaker EpiPen sales

Friday 2nd November 2018

AbbVie/arthritis drugs: copycat flap

Pharm group’s patent loss will be the gain of healthcare funders

FT Health: Tackling toxic air

Booze and drugs toll, paraplegic patients walk again, dog detectives

Wednesday 31st October 2018

UK drugmaker ITH Pharma charged after baby deaths

London-based group to ‘vigorously defend’ case linked to contaminated feed

GSK’s shingles vaccine helps it shrug off Advair fears

UK drugmaker tightens full-year guidance towards upper end of expectations

Shingles vaccine helps GSK shrug off Advair threat

Takeda raises forecast on cancer drug outlook

Innovent Biologics gains by a fifth on Hong Kong debut

Chinese biotech group breaks with string of poor performances by peers

Tuesday 30th October 2018

Pfizer outlook dented by strong dollar and legacy drug unit

Friday 26th October 2018

FT Health: Health for all or health for some?

Astana 2018, Tedros interview, medicinal cannabis


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks